Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer Read more
Bioniz Therapeutics Announces Positive Phase 1b Clinical Study Results for Investigational Agent BNZ-1 Read more
Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab Read more